# Anadys Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anadys-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Total disclosed funding: $6.6M
- Latest round: Series B (May 18, 1995)
- Investors on record: 6

## About

Founded in 1992 and based in California, US, Anadys Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing medicines for the treatment of hepatitis C virus and bacterial infections.

## Funding rounds

- Series B, May 18, 1995, $6.6M — Accel, Advent International, Atlas Venture, New Enterprise Associates, CW Group, Venrock

## Investors

- Accel (https://capitalatlas.ai/funds/accel) — Series B
- Advent International (https://capitalatlas.ai/funds/advent-international) — Series B
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series B
- CW Group (https://capitalatlas.ai/funds/cw-group) — Series B
- Venrock (https://capitalatlas.ai/funds/venrock) — Series B